According to information from the newspaper WorldHE Butantane Institute It is negotiating to partner with the US National Institutes of Health (NIH) to produce a national vaccine against monkey flower🇧🇷 If the partnership is concluded, the biological material will be sent to Brazil for Bhutantan to study and produce the vaccine in the country.
After transferring the biological content, the institute’s scientists will be able to use the cell and virus banks to understand the process of developing a new immunizer against the disease. In other words, it will not be the production of an already produced vaccine, but the creation of a vaccine from a new process.
“We await formalization of the partnership with the NIH so that Butantaneous begins to build expertise for a possible vaccine production. “The goal is to have a safe end product with efficacy and immunogenicity.”
Brazilian vaccine
According to Ana Marisa Chudzinski-Tavassi, director of the Bhutantan Center for Development and Innovation, the first goal is to study the biological material and understand how it is possible to create a vaccine. After this stage, the institute aims to start production and conduct pre-clinical and clinical studies.
In any case, it is important to underline that the partnership between the institutions has not yet been concluded. In fact, at the request of the Vaccine Technology Center (CTVAcinas) at the Federal University of Minas Gerais (UFMG), the NIH has already sent two virus samples to Brazil to produce a Brazilian vaccine.
Source: Tec Mundo
I am Bret Jackson, a professional journalist and author for Gadget Onus, where I specialize in writing about the gaming industry. With over 6 years of experience in my field, I have built up an extensive portfolio that ranges from reviews to interviews with top figures within the industry. My work has been featured on various news sites, providing readers with insightful analysis regarding the current state of gaming culture.
